Alison Generotti Selected Research

reluscovtogene ralaplasmid

1/2022	Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primates.
10/2021	Intradermal-delivered DNA vaccine induces durable immunity mediating a reduction in viral load in a rhesus macaque SARS-CoV-2 challenge model.
1/2020	Immunogenicity of a DNA vaccine candidate for COVID-19.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Alison Generotti Research Topics

Disease

3	COVID-19 01/2022 - 01/2020
1	Infections 01/2022

Drug/Important Bio-Agent (IBA)

3	reluscovtogene ralaplasmidIBA 01/2022 - 01/2020
2	VaccinesIBA 01/2022 - 01/2020
1	DNA VaccinesIBA 01/2022
1	AntibodiesIBA 01/2020
1	A-Form DNA (A-DNA)IBA 01/2020
1	AntigensIBA 01/2020